← All stocks

Traws Pharma, Inc.

TRAW Net buying
CIK 0001130598 #5313 in the set updated 18 Sep 2026
Bought (120 mo)
$12.49M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.64M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.64M
26 of 26 sales
Net
+$10.85M
+$10.85M against sales at will

By person

26 insiders · 76 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
TYNDALL CAPITAL PARTNERS L P entity
10% owner
$5.42M (2)
$352.49K (12)
+$5.07M
616,389
$1.03M
683 Capital Management, LLC entity
Former 10% Owner
$5.24M (2)
$1.03M (5)
+$4.21M
460,000
$768.20K
ORBIMED ADVISORS LLC entity
10% owner
$998.21K (1)
+$998.21K
1,203,250
$2.01M
+98.7%
Reddy E Premkumar
Director
$350.00K (3)
$143.95K (1)
+$206.05K
16,683
$27.86K
MARINO JAMES J
Director
$126.62K (8)
+$126.62K
21,334
$35.63K
Hoffman Michael B
Director
(1)
$95.32K (6)
−$95.32K
5,753,600
$9.61M
+50.4%
Fruchtman Steven M
PRESIDENT, CHIEF EXECUTIVE OFF
$80.02K (5)
+$80.02K
74,792
$124.90K
OLER ABRAHAM N.
SVP Corp Dev & Gen Counsel
$72.85K (11)
+$72.85K
24,514
$40.94K
Kumar Ramesh
Chief Executive Officer
$50.00K (1)
+$50.00K
102,227
$170.72K
+30.4%
MEHTA VIREN
Director
$50.00K (1)
+$50.00K
250,967
$419.11K
+25,853%
Guerin Mark Patrick
Chief Financial Officer
$48.62K (6)
+$48.62K
39,255
$65.56K
Shoemaker Mary Teresa
Director
$23.00K (2)
+$23.00K
6,292
$10.51K
ARMISTICE CAPITAL, LLC entity
10% owner
$13.02K (2)
−$13.02K
1,633,404
$2.73M
−0.6%
Bienen Henry S
Director
$11.80K (2)
+$11.80K
22,724
$37.95K
+154.9%
Gelder Mark S. MD
CHIEF MEDICAL OFFICER
$10.00K (1)
+$10.00K
10,487
$17.51K
GROOPMAN JEROME
Director
$3.63K (1)
+$3.63K
10,001
$16.70K
+1,000,000%
STOVER JACK E
Director
(1)
$0.00
6,165
$10.30K
Dukes Iain D.
Chief Executive Officer
1,816,230
$3.03M
Savchuk Nikolay
Chief Operating Officer
1,795,706
$3.00M
Pauza Charles David
Chief Science Officer Virology
115,971
$193.67K
Redfield Robert
Chief Medical Officer
113,919
$190.24K
CAUTREELS WERNER
Director
109,222
$182.40K
Parker Charles Nolan
Chief Financial Officer
15,393
$25.71K
Clarke Trafford
Director
6,157
$10.28K
Leaman John Harold
Director
4,058
$6.78K
TPAV, LLC entity
10% owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 5.1 over the window, from 3,025,554 to 15,368,277 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
CAUTREELS WERNER
18 Feb 2025
Chief Executive Officer
Exercised, kept
96,348
$0.01
$963.48
OLER ABRAHAM N.
18 Nov 2021
SVP Corp Dev & Gen Counsel
Exercised, kept
5,000
$3.00
$15.00K

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 26
Transactions with no price 5
Shares from compensation/vesting 6,347,647
Sales filed before the plan box existed 26
History held since 1 Sep 2016